Absci Corp Revenue per Employee (ABSI), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Absci Corp  (NASDAQ: ABSI)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare
 

Absci's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Absci's Revenue per employee fell on a trailing twelve month basis to $ 11,150, below the company average number of $31,774.
Within the Healthcare sector Employees of 542 other companies have achieved higher revenue per employee. While Absci's total ranking has deteriorated compared to the previous quarter from 2681 to 3630. Absci has 140 employees.


What is Sales per Employee Ratio?







ABSI Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change -46.37 % -81.76 % -2.26 % -77.78 % -53.31 %
Sales per Employee (TTM) $ 11,150 13,114 20,000 20,107 29,557
ABSI's Total Ranking # 3630 # 2681 # 3144 # 2507 # 2843
Seq. Revenue Change 47.91 % -66.92 % 71.96 % -36.26 % -49.7 %


Revenue per Employee Company Ranking
Within: No.
Medical Laboratories Industry # 32
Healthcare Sector # 543
Overall Market # 3630

Revenue per Employee Statistics
High Average Low
$ 61,157 $ 31,774 $ 5,200
(Jun 30 2023)   (Jun 30 2021)



Financial Statements
Absci's Revenue MRQ $ 0 Millions Visit ABSI's Income Statement
Absci's Revenues TTM $ 2 Millions Visit ABSI's aggregate revenue growth
What are ABSI's Sales? Visit ABSI's Sales by Segment




Other Ratios
Absci's Income per Employee
Employees in Medical Laboratories
Medical Laboratories Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ABSI's Revenue per Employee versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ABSI's Competitors
Revenue per Employee for ABSI's Suppliers
Revenue per Employee for ABSI's Customers

You may also want to know
ABSI's Sales Growth Rates ABSI's Pe Price to earnings ratio ABSI's Receivables Turnover Ratio ABSI's Stock Quote
ABSI's Net Income Growth Rates ABSI's Ps Price to Sales ratio ABSI's Sales per Employee ABSI's Asset Turnover Ratio
ABSI's Net Margin ABSI's Pb Price to Book ratio ABSI's Financial Strength Ratios ABSI's Dividend Payout Ratio
Date modified: 2026-09-04T09:58:17+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
China Pharma Holdings Inc  17,710.83 $ 3.914  Million 221 
Cardiff Oncology Inc   16,387.10 $ 0.508  Million 31 
Mangoceuticals Inc   14,328.50 $ 0.315  Million 22 
Eyepoint Inc   13,028.04 $ 2.788  Million 214 
Absci Corp  11,150.00 $ 1.561  Million 140 
Pluri Inc   11,043.48 $ 1.016  Million 92 
Pulse Biosciences Inc   10,215.52 $ 1.185  Million 116 
Roivant Sciences Ltd   10,042.67 $ 7.532  Million 750 
Skinvisible Inc   10,000.00 $ 0.020  Million 2 
Aclarion Inc   7,615.27 $ 0.084  Million 11 
Lightwave Logic Inc   7,360.32 $ 0.250  Million 34 
Co diagnostics Inc   6,272.93 $ 0.721  Million 115 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.